These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 34634098)
1. Considerations in Pfizer-BioNTech COVID-19 vaccine preparation in clinic: Quality vs quantity. Jin CH; Tran LM; Rivero CJ; Childs RR Am J Health Syst Pharm; 2022 Feb; 79(5):325-327. PubMed ID: 34634098 [TBL] [Abstract][Full Text] [Related]
2. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]
3. A case of hemichorea following administration of the Pfizer-BioNTech COVID-19 vaccine. Ryu DW; Lim EY; Cho AH Neurol Sci; 2022 Feb; 43(2):771-773. PubMed ID: 34811599 [No Abstract] [Full Text] [Related]
4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021. Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ; MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654 [TBL] [Abstract][Full Text] [Related]
6. Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency. Fernandez Salinas A; Piano Mortari E; Terreri S; Milito C; Zaffina S; Perno CF; Locatelli F; Quinti I; Carsetti R J Allergy Clin Immunol; 2022 Jan; 149(1):76-77. PubMed ID: 34674857 [No Abstract] [Full Text] [Related]
8. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. Havla J; Schultz Y; Zimmermann H; Hohlfeld R; Danek A; Kümpfel T J Neurol; 2022 Jan; 269(1):55-58. PubMed ID: 34115170 [No Abstract] [Full Text] [Related]
9. Comments on "Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine" by , J Neuroimmunol. Caravagna C J Neuroimmunol; 2022 Jan; 362():577780. PubMed ID: 34826735 [No Abstract] [Full Text] [Related]
10. Viral-like Reaction or Hypersensitivity? Erythema Multiforme Minor Reaction and Moderate Eosinophilia After the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 Vaccine. de Las Vecillas L; López J; Morchón E; Rodriguez F; Drake M; Martino M J Investig Allergol Clin Immunol; 2021 Feb; 32(1):77-78. PubMed ID: 34588156 [No Abstract] [Full Text] [Related]
11. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases. Hartley JL; Bailey N; Sharma A; Shawki H BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429 [TBL] [Abstract][Full Text] [Related]
13. Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine. Giuffrida G; Condorelli A; Di Giorgio MA; Markovic U; Sciortino R; Nicolosi D; Di Raimondo F Haematologica; 2022 Apr; 107(4):1008-1010. PubMed ID: 34382388 [No Abstract] [Full Text] [Related]
14. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. Rabinowich L; Grupper A; Baruch R; Ben-Yehoyada M; Halperin T; Turner D; Katchman E; Levi S; Houri I; Lubezky N; Shibolet O; Katchman H J Hepatol; 2021 Aug; 75(2):435-438. PubMed ID: 33892006 [TBL] [Abstract][Full Text] [Related]
15. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection. Costanzo M; De Giglio MAR; Roviello GN Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678 [TBL] [Abstract][Full Text] [Related]